Volume 22, Number 5—May 2016
CME ACTIVITY - Research
Spectrum of Viral Pathogens in Blood of Malaria-Free Ill Travelers Returning to Canada
Ruwandi Kariyawasam, Rachel Lau, Alireza Eshaghi, Samir N. Patel, Doug Sider, Jonathan B. Gubbay, and Andrea K. Boggild
Table 3
Region of travel for patients from Canada who had viral pathogen–positive specimens after returning ill from travel, May 2006–April 2007 and February 2013–March 2014*
| Viral pathogen | Total no. pathogens detected | No. (%) specimens with patient travel history noted | Region of travel, no. patients |
|---|---|---|---|
| HSV | |||
| HSV-1 | 7 | 4 (57.1) | Afghanistan, 1; Caribbean, 1; Haiti, 1; Hawaii, 1 |
| HSV-2 |
14 |
6 (42.9) |
Dominican Republic, 3; India, 1; Sri Lanka, 1; Venezuela, 1 |
| EBV |
194 |
96 (47.7) |
Indian subcontinent, 34; Caribbean, 21; Africa, 17; South America, 7; Central America, 5; Southeast Asia, 5; North America, 4; Middle East, 3 |
| CMV |
4 |
2 (50.0) |
Pakistan, 1; South America, 1 |
| Chikungunya virus |
5 |
3 (60.0) |
Barbados, 1; Philippines, 1; South Africa, 1 |
| Dengue virus, serotype | 33 | 20 (60.6) | |
| DENV-1 | 12 | 10 (83.3) | Barbados, 4; Cambodia, 1; Caribbean, 1; Dominican Republic, 1; India, 1; Sri Lanka, 1; Trinidad, 1 |
| DENV-2 | 3 | 3 (100) | Bangladesh, 1; Cuba, 1; Tanzania, 1 |
| DENV-3 | 9 | 2 (22.2) | Indonesia, 1; Philippines/Vietnam, 1 |
| DENV-4 | 3 | 2 (66.7) | Vietnam, 2 |
| Untypeable dengue |
6 |
3 (50.0) |
Guyana, 1; Malaysia, 1; Yemen, 1 |
| Untypeable flavivirus |
2 |
1 (50.0) |
Barbados, 1 |
| HAV | 12 | 4 (33.3) | Pakistan, 3; Bangladesh, 1 |
*Data are for 129 (49.2%) of 262 EDTA-containing specimens. CMV, cytomegalovirus; DENV-1–4, dengue virus type 1–4; EBV, Epstein-Barr virus; HAV, hepatitis A virus; HSV-1 and 2, herpes simplex 1 and 2 virus.
Page created: April 02, 2018
Page updated: April 02, 2018
Page reviewed: April 02, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.